comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-02 00:28:40 - browse：51683

Americans who suffer severe allergic reactions won’t have alternatives to auto-injectors like the EpiPen for a while longer. In a surprise move, the Food and Drug Administration on Tuesday declined to approve neffy, an epinephrine nasal spray. Instead, the FDA asked the drug’s manufacturer, ARS Pharma, to conduct further studies, specifically comparing the effect of repeat doses of epinephrine administered via nasal spray versus auto-injection in people with allergic rhinitis, or hay fever.

This was unexpected, and disappointing, for ARS Pharma: In May, an FDA advisory committee had voted 16-6 in favor of neffy’s approval for adults, and 17-5 in favor for children. But there is at least one party that’s likely to benefit from this development: Viatris, the maker of EpiPen, the brand-name epinephrine auto-injector used to treat anaphylaxis. (A generic version is also available, made by Teva).

In June, Viatris filed a citizen petition with the FDA, saying that the available evidence left doubts about how neffy would actually perform in a real-life anaphylactic event compared to auto-injectable epinephrine.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： How to fix the rural physician shortage in the U.S.

WSS

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Kenai launches with $82 million for Parkinson’s stem cell therapy

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Scientists unlock the key to scar

knowledge

comprehensive

Wikipedia

Medical records are filled with copy

‘Oppenheimer’ and the risks of AI in health care

Dobbs anniversary: the lost opportunity of abortion as health care

How to fix the rural physician shortage in the U.S.

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Activists slam private health insurers over coverage restrictions

Covid isolation guidance eased by the CDC

Bright Health sells Medicare Advantage business to Molina

What to expect as Trump is arraigned on his Jan 6. indictment

entertainment

Kenai launches with $82 million for Parkinson’s stem cell therapy

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

FogPharma raises $145 million in rare Series E round

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Clinical trials giant ICON acquires HumanFirst

focus

leisure time

focus

knowledge